The VEDS Movement Statement: Upcoming Events

Picture of a calendar- VEDS Movement events postponed

The VEDS Movement, a division of The Marfan Foundation, is working closely with our Professional Advisory Board, which consists of the leading medical experts on VEDS, Marfan and related conditions, on issues surrounding COVID-19 (coronavirus). In response to the recent spread and risks associated with coronavirus, the Foundation is postponing several in-person events scheduled in the coming weeks. We…

Read More

New Statement Regarding COVID-19 and Genetic Aortic Conditions

Covid 19 red and white

The Marfan Foundation and The VEDS Movement, in collaboration with our Professional Advisory Board (PAB), continues to monitor the news regarding COVID-19 and wants to provide updated information for our community. We would like to reaffirm the recommendations issued by the Centers for Disease Control and Prevention (CDC) regarding the virus and want to add specific information for the…

Read More

The VEDS Movement Statement on COVID 19

Covid 19 red and white

With the anticipated spread of the novel coronavirus, COVID 19, in the United States, The VEDS Movement, in collaboration with members of our Professional Advisory Board, would like to echo some of the Center for Disease Control (CDC) guidance regarding the virus for the Vascular Ehlers-Danlos Syndrome (VEDS) community. We are monitoring the risks associated with COVID 19 and,…

Read More

New Research Reveals Signaling Pathway, Paving the Way for the Study of New Treatments for VEDS

Gray and white mouse looking at camera

A new research paper, titled Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome was published electronically on December 17, 2019 in the Journal of Clinical Investigation. In this research study, researchers from Johns Hopkins University School of Medicine created two mouse models of VEDS (with similar glycine substitutions to those found in individuals with VEDS), and…

Read More

Your Medical ID

picture of a medical alert bracelet

Do you have VEDS and struggle with what information to put on your medical ID or medical alert bracelet? You are not alone. Individuals with VEDS are at a high risk of life-threatening complications like arterial ruptures and dissections (including the aorta), organ ruptures (particularly the bowel and uterus), carotid-cavernous sinus fistula, and lung collapse. It may feel daunting…

Read More

The vEDS Collaborative Clinical Trial Planning Survey

vEDS Collaborative and cooperating organizations

The VEDS Movement is a member of the vEDS Collaborative, a research group led by Sherene Shalhub, MD that has worked to bring together doctors, researchers, and individuals with Vascular Ehlers-Danlos Syndrome (VEDS). The vEDS Collaborative is currently enrolling individuals in a natural history study, and is planning a clinical trial to compare the effectiveness of medications currently used…

Read More

The VEDS Movement is Published in an International Emergency Medicine Journal

Notebook glasses and pen

On August 25, 2019, the international Advanced Journal of Emergency Medicine (AJEM) published an article titled The Current Status of Genes and Genetic Testing in Emergency Medicine: A Narrative Review.   The article included a description of VEDS (Vascular Ehlers-Danlos Syndrome), as well as the importance of the genetic testing information to the emergency physician. We at The VEDS Movement…

Read More

The VEDS Movement Launches

Four young women sitting together smiling

The VEDS Movement is excited to announce the launch of its website for the VEDS community, “This is a huge step towards reducing the confusion between Vascular Ehlers-Danlos syndrome (VEDS) and other forms of Ehlers-Danlos Syndrome (EDS),” said Katie Wright, director of the Movement. “The website is also designed to provide the VEDS community with the most up-to-date…

Read More

New Virtual Support Groups for VEDS

Woman in pink coat in front of the computer smiling

The VEDS Movement is pleased to announce four new virtual support groups for the VEDS community. This effort is spearheaded by Katie Wright, director of The Marfan Foundation’s new VEDS division. Each support group will meet once a month using online meeting technology. Those who are unable to join online can participate by phone. “We are very excited to…

Read More

Professional Advisory Board Statement on the FDA Warning Concerning Fluoroquinolones

PAB statement on fluoroquinolones and Marfan, Loeys-Dietz, Vascular Ehlers-Danlos (VEDS)

In December 2018, the US Food and Drug Administration (FDA) issued a warning against the use of fluoroquinolones in people with Marfan syndrome and other related genetic aortic conditions. The FDA’s warning indicated that fluoroquinolones, a commonly prescribed class of antibiotics that includes Avelox, Cipro, Factive, Levaquin, and Ofloxacin, should not be used in people with certain genetic conditions…

Read More